Patents by Inventor Jaime Darce

Jaime Darce has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-ILT3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
    Publication number: 20250092132
    Abstract: Disclosed herein are anti-immunoglobulin-like transcript-3 (ILT3) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Application
    Filed: September 6, 2024
    Publication date: March 20, 2025
    Inventors: Jaime Darce, Scott Michael Lonning, Nels Eric Pederson, Klarisa Rikova, Aleksandr Tkachev
  • Anti-ILT3 antibodies and antibody drug conjugates
    Patent number: 11267886
    Abstract: Disclosed herein are anti-immunoglobulin-like transcript-3 (ILT3) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: March 8, 2022
    Assignee: Bluefin BioMedicine, Inc.
    Inventors: Jaime Darce, Scott Michael Lonning, Nels Eric Pederson, Klarisa Rikova, Aleksandr Tkachev
  • ANTI-ILT3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
    Publication number: 20200031926
    Abstract: Disclosed herein are anti-immunoglobulin-like transcript-3 (ILT3) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Application
    Filed: February 9, 2018
    Publication date: January 30, 2020
    Applicant: Bluefin BioMedicine, Inc.
    Inventors: Jaime Darce, Scott Michael Lonning, Nels Eric Pederson, Klarisa Rikova, Aleksandr Tkachev